OUR CURRENT CLINICAL TRIALS

 

SIBO STUDY

We are studying the effects of two dosing regimens of a new non-absorbable antibiotic in the treatment of Small Intestinal Bacterial Overgrowth (SIBO).

 

PEPTO-BISMOL STUDY

In conjunction with the Centers for Disease Control and Prevention (CDC) we are analyzing Pepto-Bismol in the Prevention of Travelers’ Diarrhea
 

Please select the study subject that interests you and contact our office at admin@connormd.com to find out if you are eligible to participate.

Font Resize
Contrast